Search for content, post, videos

Janssen Joins Dementia Project

Johnson & Johnson’s Janssen Pharmaceutical Companies plan to invest $10 million in a new UK government-led global dementia discovery fund for research to find ways to prevent and treat dementia and Alzheimer's disease. The investment will come through its affiliate venture arm, Johnson & J
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.